We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIET icon
11376
Hoya Capital High Dividend Yield ETF
RIET
$109M
$105K ﹤0.01%
+10,404
New +$111K
LUNA
11377
PUT
DELISTED
Luna Innovations Incorporated
LUNA
$105K ﹤0.01%
+48,600
New +$86K
ABUS icon
11378
PUT
Arbutus Biopharma
ABUS
$924M
$105K ﹤0.01%
32,100
-3,600
-10% -$13.2K
WLACU
11379
DELISTED
Willow Lane Acquisition Corp Unit
WLACU
$105K ﹤0.01%
+10,517
New +$105K
CUB
11380
Lionheart Holdings
CUB
$284M
$105K ﹤0.01%
+10,375
New +$104K
SPGP icon
11381
PUT
Invesco S&P 500 GARP ETF
SPGP
$2.33B
$105K ﹤0.01%
1,000
-1,000
-50% -$108K
HCI icon
11382
PUT
HCI Group
HCI
$2.29B
$105K ﹤0.01%
+900
New +$103K
APYX icon
11383
Apyx Medical
APYX
$128M
$105K ﹤0.01%
66,355
+53,782
+428% +$75.2K
KNSA icon
11384
CALL
Kiniksa Pharmaceuticals
KNSA
$5.99B
$105K ﹤0.01%
5,300
-4,400
-45% -$100K
EUO icon
11385
CALL
ProShares UltraShort Euro
EUO
$33.1M
$105K ﹤0.01%
3,000
-5,600
-65% -$184K
CTLP
11386
PUT
DELISTED
Cantaloupe
CTLP
$105K ﹤0.01%
11,000
+4,100
+59% +$37.3K
FRHC icon
11387
CALL
Freedom Holding
FRHC
$9.34B
$105K ﹤0.01%
800
-1,000
-56% -$115K
GOVX icon
11388
GeoVax Labs
GOVX
$3.74M
$104K ﹤0.01%
+1,691
New +$97.9K
PEJ icon
11389
PUT
Invesco Leisure and Entertainment ETF
PEJ
$314M
$104K ﹤0.01%
2,000
URGN icon
11390
PUT
UroGen Pharma
URGN
$2.36B
$104K ﹤0.01%
9,800
-39,400
-80% -$472K
CVAC
11391
CALL
DELISTED
CureVac
CVAC
$104K ﹤0.01%
30,600
+7,400
+32% +$21.3K
MAPS
11392
DELISTED
WM TECHNOLOGY INC A
MAPS
$104K ﹤0.01%
+75,610
New +$81.3K
CCIRU
11393
DELISTED
Cohen Circle Acquisition Corp. I Unit
CCIRU
$104K ﹤0.01%
+10,306
New +$103K
NX icon
11394
PUT
Quanex
NX
$962M
$104K ﹤0.01%
4,300
+3,500
+438% +$100K
MOBX icon
11395
Mobix Labs
MOBX
$19.3M
$104K ﹤0.01%
+6,127
New +$62.4K
AMBP icon
11396
PUT
Ardagh Metal Packaging
AMBP
$3.13B
$104K ﹤0.01%
34,500
+28,900
+516% +$104K
CIO
11397
CALL
DELISTED
City Office REIT
CIO
$104K ﹤0.01%
18,800
-9,000
-32% -$49.4K
VCICU
11398
DELISTED
Vine Hill Capital Investment Corp Unit
VCICU
$104K ﹤0.01%
+10,283
New +$103K
RYZ
11399
PUT
Ryerson Holding Corp
RYZ
$1.5B
$104K ﹤0.01%
5,600
-4,000
-42% -$89.8K
CCRN
11400
PUT
DELISTED
Cross Country Healthcare
CCRN
$104K ﹤0.01%
5,700
+3,600
+171% +$48.5K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.